Cardiovascular Systems, Inc. – NASDAQ:CSII
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 2 hours
Cardiovascular Systems stock price monthly change
+0.70%
month
Cardiovascular Systems stock price quarterly change
+49.48%
quarter
Cardiovascular Systems stock price yearly change
+0.15%
year
Cardiovascular Systems key metrics
Market Cap | 843.96M |
Enterprise value | N/A |
P/E | -20.7 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | 4.41 |
Price/Book | 3292.19 |
PEG ratio | 0.12 |
EPS | -0.95 |
Revenue | 236.22M |
EBITDA | -32.46M |
Income | -36.93M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -16.8% |
Oper. margin | -16.84% |
Gross margin | 73.23% |
EBIT margin | -16.84% |
EBITDA margin | -13.74% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeCardiovascular Systems stock price history
Cardiovascular Systems stock forecast
Cardiovascular Systems financial statements
| Sep 2021 | 58.37M | -8.61M | -14.76% |
|---|---|---|---|
| Dec 2021 | 59.13M | -8.96M | -15.16% |
| Mar 2022 | 56.22M | -9.65M | -17.18% |
| Jun 2022 | 62.49M | -9.69M | -15.5% |
| Mar 2022 | 323991000 | 70.49M | 21.76% |
|---|---|---|---|
| Jun 2022 | 322677000 | 73.19M | 22.68% |
| Sep 2022 | 312038000 | 69.88M | 22.4% |
| Dec 2022 | 311506000 | 72.11M | 23.15% |
| Sep 2021 | -10.78M | 11.60M | -5.02M |
|---|---|---|---|
| Dec 2021 | -1.53M | -497K | 1.02M |
| Mar 2022 | -2.12M | 3.37M | -159K |
| Jun 2022 | -9.82M | 7.67M | 1.62M |
Cardiovascular Systems alternative data
| Aug 2023 | 725 |
|---|---|
| Sep 2023 | 725 |
| Oct 2023 | 725 |
| Nov 2023 | 725 |
| Dec 2023 | 725 |
| Jan 2024 | 725 |
| Feb 2024 | 725 |
| Mar 2024 | 725 |
| Apr 2024 | 725 |
| May 2024 | 725 |
| Jun 2024 | 725 |
| Jul 2024 | 725 |
Cardiovascular Systems other data
54.20%
-38.45%
of CSII is owned by hedge funds
102
-60
21.49M
-15.19M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Feb 2022 | 9067 | 0 |
| May 2022 | 6000 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | ARONSON MARTHA GOLDBERG director | Restricted Stock Units | 2,411 | N/A | N/A | ||
Option | ARONSON MARTHA GOLDBERG director | Common Stock | 2,411 | N/A | N/A | ||
Purchase | POINTS JEFFREY S. officer: Chief Fi.. | Common Stock | 3,000 | $14.5 | $43,497 | ||
Purchase | WARD SCOTT R. director, officer: Chairman and.. | Common Stock | 3,000 | $14.49 | $43,467 | ||
Purchase | PAULSEN ERIK director | Common Stock | 500 | $19.05 | $9,523 | ||
Purchase | POINTS JEFFREY S. officer: Chief Fi.. | Common Stock | 2,000 | $18.2 | $36,400 | ||
Purchase | ARONSON MARTHA GOLDBERG director | Common Stock | 2,500 | $18.43 | $46,075 | ||
Purchase | ROBB RHONDA J. officer: Chief Op.. | Common Stock | 1,567 | $18.72 | $29,326 | ||
Purchase | WARD SCOTT R. director, officer: Chairman and.. | Common Stock | 2,500 | $18.52 | $46,293 | ||
Purchase | POINTS JEFFREY S. officer: Chief Fi.. | Common Stock | 1,000 | $34.2 | $34,200 |
| Patent |
|---|
Grant Utility: Methods for counteracting rebounding effects during solid state resistance welding of dissimilar materials Filling date: 10 Jun 2020 Issue date: 13 Sep 2022 |
Grant Filling date: 20 Aug 2019 Issue date: 13 Sep 2022 |
Grant Filling date: 19 Jun 2019 Issue date: 13 Sep 2022 |
Application Filling date: 24 May 2022 Issue date: 8 Sep 2022 |
Application Filling date: 11 Jan 2022 Issue date: 8 Sep 2022 |
Grant Filling date: 25 Mar 2019 Issue date: 6 Sep 2022 |
Application Filling date: 19 May 2022 Issue date: 1 Sep 2022 |
Grant Filling date: 30 Oct 2019 Issue date: 30 Aug 2022 |
Application Filling date: 24 Feb 2022 Issue date: 25 Aug 2022 |
Application Filling date: 25 Apr 2022 Issue date: 11 Aug 2022 |
| Quarter | Transcript |
|---|---|
| Q1 2023 5 Nov 2022 | Q1 2023 Earnings Call Transcript |
| Q3 2022 8 May 2022 | Q3 2022 Earnings Call Transcript |
| Q2 2022 3 Feb 2022 | Q2 2022 Earnings Call Transcript |
| Q1 2022 9 Nov 2021 | Q1 2022 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Mr. Scott Raymond Ward B.Sc., M.S., MS (1960) Chairman, Pres & Chief Executive Officer | $1,460,000 |
| Ms. Rhonda J. Robb (1968) Chief Operating Officer | $954,830 |
| Mr. Jeffrey S. Points (1977) Chief Financial Officer | $682,690 |
| Mr. Alexander Rosenstein (1972) Gen. Counsel & Corporation Sec. | $614,960 |
| Dr. Ryan D. Egeland M.D., Ph.D. (1975) Chief Medical Officer | $522,930 |
-
When is Cardiovascular Systems's next earnings date?
Unfortunately, Cardiovascular Systems's (CSII) next earnings date is currently unknown.
-
Does Cardiovascular Systems pay dividends?
No, Cardiovascular Systems does not pay dividends.
-
How much money does Cardiovascular Systems make?
Cardiovascular Systems has a market capitalization of 843.96M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 8.79% to 236.22M US dollars.
-
What is Cardiovascular Systems's stock symbol?
Cardiovascular Systems, Inc. is traded on the NASDAQ under the ticker symbol "CSII".
-
What is Cardiovascular Systems's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Cardiovascular Systems?
Shares of Cardiovascular Systems can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Cardiovascular Systems's key executives?
Cardiovascular Systems's management team includes the following people:
- Mr. Scott Raymond Ward B.Sc., M.S., MS Chairman, Pres & Chief Executive Officer(age: 65, pay: $1,460,000)
- Ms. Rhonda J. Robb Chief Operating Officer(age: 57, pay: $954,830)
- Mr. Jeffrey S. Points Chief Financial Officer(age: 48, pay: $682,690)
- Mr. Alexander Rosenstein Gen. Counsel & Corporation Sec.(age: 53, pay: $614,960)
- Dr. Ryan D. Egeland M.D., Ph.D. Chief Medical Officer(age: 50, pay: $522,930)
-
How many employees does Cardiovascular Systems have?
As Jul 2024, Cardiovascular Systems employs 725 workers.
-
When Cardiovascular Systems went public?
Cardiovascular Systems, Inc. is publicly traded company for more then 19 years since IPO on 28 Jun 2006.
-
What is Cardiovascular Systems's official website?
The official website for Cardiovascular Systems is csi360.com.
-
Where are Cardiovascular Systems's headquarters?
Cardiovascular Systems is headquartered at 1225 Old Highway 8 Northwest, Saint Paul, MN.
-
How can i contact Cardiovascular Systems?
Cardiovascular Systems's mailing address is 1225 Old Highway 8 Northwest, Saint Paul, MN and company can be reached via phone at +65 12591600.
Cardiovascular Systems company profile:
Cardiovascular Systems, Inc.
csi360.comExchange:
NASDAQ
Full time employees:
725
Industry:
Medical - Devices
Sector:
Healthcare
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. In addition, it offers guidewires, catheters, balloons, embolic protection system, and other OAS support products. Cardiovascular Systems, Inc. has a partnership with Chansu Vascular Technologies, LLC to develop novel peripheral and coronary everolimus drug-coated balloons. The company was formerly known as Shturman Cardiology Systems, Inc. and changed its name to Cardiovascular Systems, Inc. in January 2003. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota.
1225 Old Highway 8 Northwest
Saint Paul, MN 55112-6416
Saint Paul, MN 55112-6416
CIK: 0001180145
ISIN: US1416191062
CUSIP: 141619106
